BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dawwas MF, Davies SE, Griffiths WJH, Lomas DA, Alexander GJ. Prevalence and Risk Factors for Liver Involvement in Individuals with PiZZ-related Lung Disease. Am J Respir Crit Care Med 2013;187:502-8. [DOI: 10.1164/rccm.201204-0739oc] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Cummings EE, O'Reilly LP, King DE, Silverman RM, Miedel MT, Luke CJ, Perlmutter DH, Silverman GA, Pak SC. Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. PLoS One 2015;10:e0141542. [PMID: 26512890 DOI: 10.1371/journal.pone.0141542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Wooddell CI, Blomenkamp K, Peterson RM, Subbotin VM, Schwabe C, Hamilton J, Chu Q, Christianson DR, Hegge JO, Kolbe J, Hamilton HL, Branca-Afrazi MF, Given BD, Lewis DL, Gane E, Kanner SB, Teckman JH. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease. JCI Insight 2020;5:135348. [PMID: 32379724 DOI: 10.1172/jci.insight.135348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
3 Mela M, Smeeton W, Davies SE, Miranda E, Scarpini C, Coleman N, Alexander GJM. The Alpha-1 Antitrypsin Polymer Load Correlates With Hepatocyte Senescence, Fibrosis Stage and Liver-Related Mortality. Chronic Obstr Pulm Dis 2020;7:151-62. [PMID: 32726073 DOI: 10.15326/jcopdf.7.3.2019.0158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pons M, Núñez A, Esquinas C, Torres-Durán M, Rodríguez-Hermosa JL, Calle M, Tubio-Pérez R, Belmonte I, Rodríguez-Frías F, Rodríguez E, Genescà J, Miravitlles M, Barrecheguren M. Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency. J Clin Med 2021;10:1724. [PMID: 33923569 DOI: 10.3390/jcm10081724] [Reference Citation Analysis]
5 Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis 2016;3:668-82. [PMID: 28848891 DOI: 10.15326/jcopdf.3.3.2015.0182] [Cited by in Crossref: 40] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
6 Rodríguez-Romero E, Suárez-Cuenca JA, Elizalde-Barrera CI, Mondragón-Terán P, Martínez-Hernández JE, Gómez-Cortés E, Pérez-Cabeza de Vaca R, Hernández-Muñoz RE, Melchor-López A, Jiménez-Saab NG. Low serum levels of alpha1 anti-trypsin (α1-AT) and risk of airflow obstruction in non-primary α1-AT-deficient patients with compensated chronic liver disease. Med Sci Monit 2015;21:1194-9. [PMID: 25913248 DOI: 10.12659/MSM.893350] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Mandorfer M, Bucsics T, Hutya V, Schmid-Scherzer K, Schaefer B, Zoller H, Ferlitsch A, Peck-Radosavljevic M, Trauner M, Ferenci P, Kneussl M, Reiberger T. Liver disease in adults with α1-antitrypsin deficiency. United European Gastroenterol J 2018;6:710-8. [PMID: 30083333 DOI: 10.1177/2050640618764057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Trapnell BC, Luisetti M. The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis. Orphanet J Rare Dis 2013;8:153. [PMID: 24079310 DOI: 10.1186/1750-1172-8-153] [Reference Citation Analysis]
9 Lin HC, Kasi N, Quiros JA. Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood. Curr Pediatr Rev 2019;15:53-61. [PMID: 30421678 DOI: 10.2174/1573396314666181113094517] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Cathomas M, Schüller A, Candinas D, Inglin R. Severe postoperative wound healing disturbance in a patient with alpha-1-antitrypsin deficiency: the impact of augmentation therapy. Int Wound J 2015;12:601-4. [PMID: 25818083 DOI: 10.1111/iwj.12419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
11 Borel F, Tang Q, Gernoux G, Greer C, Wang Z, Barzel A, Kay MA, Shultz LD, Greiner DL, Flotte TR, Brehm MA, Mueller C. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. Mol Ther 2017;25:2477-89. [PMID: 29032169 DOI: 10.1016/j.ymthe.2017.09.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]